Annual Report

Overview

The report is PuraPharm's first ESG report, covering operations in Hong Kong, China, Japan, Canada and Australia and highlighting extensive stakeholder engagement, employee wellbeing and community contributions. It reports HK$4,923,000 of donations, sponsorships and scholarships in 2016. Environmental KPI development and data collection had just begun, alongside resource-efficiency initiatives at the Nanning plant.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Publication date: 27 March 2017
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services